Maesa — which designs, develops and manufactures private label and exclusive brands for retailers, as well as packaging and turnkey products for beauty brands — has appointed industry vet Shawn Haynes to the newly created position of SVP of sales, mass and drugstore retailers.
The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.
Prestige lip color sales in the United States experienced a 24% increase in dollar sales during the month of November as the bold lip trend shows little signs of fading, according to global information company, The NPD Group.
The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.
The Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.
AB Acquisition LLC (Albertsons) and Safeway have entered into agreements to sell 168 stores across eight states to four buyers — Associated Food Stores, Associated Wholesale Grocers, Supervalu and Haggen.